Humacyte Inc

NASDAQ:HUMA   1:00:00 PM EDT
3.17
-0.07 (-2.16%)
2:53:58 PM EDT: $3.17 0.00 (0.00%)
Earnings Announcements

Humacyte Third Quarter 2022 Financial Results

Published: 11/10/2022 12:34 GMT
Humacyte Inc (HUMA) - Humacyte Third Quarter 2022 Financial Results and Business Update.
Reported Cash, Cash Equivalents and Short-term Investments of $171.7 Million As of September 30, 2022.
Believes Cash, Cash Equivalents and Short-term Investments Are Adequate to Fund Operations Through 2024.
Qtrly Net Loss per Share, Basic and Diluted $0.25.
Q3 Earnings per Share View $-0.22 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.23 Million
Adjusted EPS is expected to be -$0.23

Next Quarter Revenue Guidance is expected to be $0.22 Million
Next Quarter EPS Guidance is expected to be -$0.23

More details on our Analysts Page.